LeMaitre Vascular - 13 Year Stock Split History | LMAT

Stock split history for LeMaitre Vascular since 2006. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values.
LeMaitre Vascular Annual Stock Splits
LeMaitre Vascular Quarterly Stock Splits
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.536B $0.106B
LeMaitre Vascular, Inc. is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects the people worldwide. LeMaitre develops, manufactures, and markets disposable and implantable vascular devices to address the needs of vascular surgeons and interventionalists. LeMaitre's diversified product portfolio consists of twelve well-known brand name products used in arteries and veins outside of the heart and are supported by a growing, specialized and highly trained organization of vascular sales professionals. LeMaitre Vascular offers a wide range of innovative products to vascular surgeons and interventionalists for improving procedure efficacy and minimizing patient recovery time.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $148.773B 28.88
Medtronic (MDT) Ireland $132.439B 18.92
Stryker (SYK) United States $74.804B 26.70
Boston Scientific (BSX) United States $57.935B 27.77
Baxter (BAX) United States $41.482B 26.15
Zimmer Biomet Holdings (ZBH) United States $24.447B 15.71
Smith & Nephew SNATS (SNN) United Kingdom $19.056B 0.00
ResMed (RMD) United States $17.285B 33.03
Canopy Growth (CGC) Canada $14.734B 0.00
Bio-Rad Laboratories (BIO) United States $9.176B 48.65
Aurora Cannabis (ACB) Canada $7.585B 74.80
Insulet (PODD) United States $7.205B 524.91
Hill-Rom Holdings (HRC) United States $7.115B 21.57
Perrigo (PRGO) Ireland $6.034B 10.20
Haemonetics (HAE) United States $6.002B 48.99
GW Pharmaceuticals (GWPH) United Kingdom $5.303B 0.00
ICU Medical (ICUI) United States $5.078B 30.30
Hutchison China MediTech (HCM) China $3.822B 0.00
Neogen (NEOG) United States $3.283B 53.38
NuVasive (NUVA) United States $3.047B 24.89
Agios Pharmaceuticals (AGIO) United States $3.019B 0.00
National Vision Holdings (EYE) United States $2.421B 51.58
Quidel (QDEL) United States $2.341B 24.30
Aphria (APHA) $1.690B 0.00
Cardiovascular Systems (CSII) United States $1.513B 869.00
HEXO (HEXO) $1.479B 0.00
Phibro Animal Health (PAHC) United States $1.209B 18.11
AtriCure (ATRC) United States $1.181B 0.00
VAREX IMAGING (VREX) United States $1.121B 23.79
Lantheus Holdings (LNTH) United States $1.092B 29.01
OrganiGram Holdings (OGI) Canada $0.973B 0.00
NanoString Technologies (NSTG) United States $0.945B 0.00
PetIQ (PETQ) United States $0.927B 22.51
Quanterix (QTRX) United States $0.859B 0.00
MacroGenics (MGNX) United States $0.817B 0.00
Omeros (OMER) United States $0.816B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.753B 21.12
Cerus (CERS) United States $0.678B 0.00
TG Therapeutics (TGTX) United States $0.676B 0.00
Surmodics (SRDX) United States $0.585B 85.04
OraSure Technologies (OSUR) United States $0.549B 25.26
Meridian Bioscience (VIVO) United States $0.499B 15.26
Evolus (EOLS) United States $0.374B 0.00
Vapotherm (VAPO) United States $0.363B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.359B 0.00
Zynex (ZYXI) United States $0.335B 34.60
BioLife Solutions (BLFS) United States $0.331B 103.53
Utah Medical Products (UTMD) United States $0.328B 22.71
Bovie Medical (APYX) United States $0.226B 0.00
Cytosorbents (CTSO) United States $0.212B 0.00
Owens & Minor (OMI) United States $0.184B 3.91
Rockwell Medical (RMTI) United States $0.180B 0.00
Chimerix (CMRX) United States $0.169B 0.00
Fonar (FONR) United States $0.135B 7.11
Female Health (VERU) United States $0.131B 0.00
Chembio Diagnostics (CEMI) United States $0.105B 0.00
BRAINSWAY LTD (BWAY) Israel $0.102B 0.00
Neurotrope (NTRP) United States $0.091B 0.00
InfuSystems Holdings (INFU) United States $0.090B 0.00
United-Guardian (UG) United States $0.088B 19.35
Surface Oncology (SURF) United States $0.088B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.062B 0.00
ImmuCell (ICCC) United States $0.049B 0.00
Trinity Biotech (TRIB) Ireland $0.039B 13.67
Senestech (SNES) United States $0.035B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.033B 0.00
GUARDION HEALTH (GHSI) United States $0.032B 0.00
Cellectar Biosciences (CLRB) United States $0.021B 0.00
Valeritas Holdings (VLRX) United States $0.016B 0.00
Myomo (MYO) United States $0.014B 0.00
Capricor Therapeutics (CAPR) United States $0.012B 0.00
Akers Biosciences Inc (AKER) United States $0.007B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.007B 0.00
NeuroMetrix (NURO) United States $0.005B 3.93